首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?
【2h】

Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?

机译:trandolapril和吲哚美辛会影响高血压患者的肾功能和肾功能储备吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

> Aims To assess the effect of trandolapril (2 mg once daily) and indomethacin (25 mg three times daily), alone and in combination, on renal function and renal functional reserve in hypertensive patients (DBP 95–115 mmHg) requiring regular non-steroidal anti-inflammatory drugs (NSAIDs). > Methods Randomized, double-blind, placebo-controlled, four way crossover design. After 3 weeks treatment renal plasma flow (RPF) and glomerular filtration rate (GFR) were measured using the p-aminohippurate (PAH) and inulin methods. Renal functional reserve was estimated by measuring RPF and GFR at the end of an intravenous infusion of dopamine 2 μg kg−1 and 10% amino acid solution. > Results There was no significant difference in RPF between treatments: −22.79 ml min−1 (95% CI −54.82, 9.24) for placebo and trandolapril, −10.37 ml min−1 (95% CI −30.7, 9.96) for placebo and indomethacin, −14.78 ml min−1 (95% CI −50.33, 20.77) for placebo and trandolapril with indomethacin. There was no significant difference in functional reserve RPF between treatments: −34.96 ml min−1 (95% CI −119.8, 49.88) for placebo and trandolapril, 29.78 ml min−1, −15.18, 74.74) for placebo and indomethacin, and −25.84 ml min−1 (95% CI −87.62, 35.94) for placebo and trandolapril with indomethacin. There was no significant difference in GFR between treatments: −1.01 ml min−1 (95% CI −7.45, 5.42) for placebo and trandolapril, −7.88 ml min−1 (95% CI −15.08, −0.68) for placebo and indomethacin, and −0.36 ml min−1 (95% CI −7.58, 6.86) for placebo and trandolapril with indomethacin. There was no significant difference in functional reserve GFR between treatments: 5.13 ml min−1 (95% CI −4.97, 15.23) for placebo and trandolapril, 6.31 ml min−1 (95% CI −1.88, 14.5) for placebo and indomethacin, 7.21 ml min−1 (95% CI 1.26, 13.16) for placebo and trandolapril with indomethacin. > Conclusion In hypertensives chronic treatment with NSAIDs or ACEI alone or in combination did not change RPF or GFR and did not change renal functional reserve capacity of RPF or GFR.
机译:> 目的:评估单独使用或联合使用的trandolapril(每天2mg,每天一次)和消炎痛(25mg,每天3次)对高血压患者肾功能和肾功能储备的影响(DBP 95–115) (mmHg)需要常规的非甾体类抗炎药(NSAIDs)。 > 方法:随机化,双盲,安慰剂对照,四向交叉设计。治疗3周后,使用对氨基马尿酸盐(PAH)和菊粉法测量肾血浆流量(RPF)和肾小球滤过率(GFR)。静脉输注多巴胺2μgkg -1 和10%氨基酸溶液结束时,通过测量RPF和GFR来估计肾功能储备。 > 结果:各处理之间的RPF值无显着差异:安慰剂和trandolapril为−22.79 ml min -1 (95%CI −54.82,9.24),− 10.37 ml min <安慰剂和消炎痛的sup> -1 (95%CI −30.7,9.96),安慰剂和吲哚美辛的trandolapril为-14.78 ml min -1 (95%CI −50.33,20.77) 。两种治疗之间的功能储备RPF差异无统计学意义:安慰剂和trandolapril为−34.96 ml min -1 (95%CI -119.8,49.88),29.78 ml min -1 ,对于安慰剂和吲哚美辛为-15.18,74.74),对于安慰剂和含吲哚美辛的trandolapril为-25.84 ml min -1 (95%CI −87.62,35.94)。两种治疗之间的GFR无显着差异:安慰剂和trandolapril为−1.01 ml min -1 (95%CI −7.45,5.42),− 7.88 ml min -1 (安慰剂和消炎痛的CI值为(95%CI -15.08,-0.68),安慰剂和含吲哚美辛的trandolapril为-0.360.3ml min -1 (95%CI −7.58,6.86)。两种处理之间的功能储备GFR没有显着差异:安慰剂和trandolapril为5.13 ml min -1 (95%CI −4.97,15.23),6.31 ml min -1 安慰剂和吲哚美辛为(95%CI −1.88,14.5),安慰剂和含吲哚美辛的trandolapril为7.21µml min -1 (95%CI 1.26,13.16)。 > 结论:在高血压患者中,单独或联合使用NSAIDs或ACEI进行慢性治疗不会改变RPF或GFR,也不会改变RPF或GFR的肾功能储备能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号